Keyphrases
Estrogen
100%
Anticancer
100%
Selective Estrogen Receptor Modulators
100%
Breast Cancer
40%
Human Epidermal Growth Factor Receptor 2 (HER2)
30%
Estrogen Receptor
30%
Antiestrogen
20%
Mitogen-activated Protein Kinase
20%
PI3K-Akt Pathway
20%
Estrogen Action
20%
Resistant Breast Cancer
20%
Induced Apoptosis
10%
Tumor Cells
10%
Drug Action
10%
Overexpression
10%
Breast Cancer Prevention
10%
Breast Cancer Treatment
10%
Breast Tumor
10%
Acquired Resistance
10%
Cardiovascular System
10%
Corepressor
10%
Resistance Mechanisms
10%
Estrogen Receptor-positive
10%
Beneficial Effects
10%
Estrogenic
10%
Mediated Action
10%
Coactivator
10%
Signaling Cascades
10%
Estrogen-responsive Genes
10%
Resistant Phenotypes
10%
Estrogen Receptor 1 (ESR1)
10%
Protein Partners
10%
Sine
10%
PI3K-AKT-mTOR Pathway
10%
Endometrial Tumor
10%
Bone System
10%
ER-β
10%
Modulator Therapy
10%
Low-dose Estrogens
10%
Medicine and Dentistry
Selective Estrogen Receptor Modulator
100%
Breast Cancer
70%
Estrogen Receptor
40%
Estrogen Activity
20%
Mitogen-Activated Protein Kinase
20%
Clinical Study
10%
Low Drug Dose
10%
Breast Tumor
10%
Receptor
10%
Programmed Cell Death
10%
Tumor Cell
10%
Cardiovascular System
10%
Kinase
10%
Drug Action
10%
Mammalian Target of Rapamycin
10%
Endometrium Tumor
10%
Tyrothricin
10%
Tamoxifen
10%
Biochemistry, Genetics and Molecular Biology
Anticancer
100%
Estrogen Receptor
100%
Conformation
14%
Estrogen Activity
14%
Mitogen-Activated Protein Kinase
14%
Clinical Study
7%
Mammalian Target of Rapamycin
7%
Drug Mechanism
7%
Transcription
7%
Low Drug Dose
7%
Corepressor
7%
Eicosanoid Receptor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Selective Estrogen Receptor Modulator
100%
Breast Cancer
70%
Estrogen Receptor
40%
Clinical Study
10%
Tamoxifen
10%
Receptor
10%
Breast Tumor
10%
Endometrium Tumor
10%
Tyrothricin
10%
Drug Action
10%